HA-functionalized nanocarriers are preferentially applied in cancer treatment [9,10,11,12], but given the important role of HA-CD44 interaction in tissues fibrosis progression, several research groups started to exploit HA-nanoparticles as drug delivery systems for liver fibrosis [13]. This evidence concerns the gene CD44 and cancer.